Galmed Pharmaceuticals Ltd. buy StockNews.com
Start price
16.11.25
/
50%
€6.40
Target price
16.11.26
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 16.11.26. The prediction end date can be changed by StockNews_com at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - |
| iShares Core DAX® | 0,44 % | 3,03 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % |
| iShares S&P 500 | 2,37 % | 2,68 % |
Comments by StockNews_com for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical (NYSE:GMED) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for GMED provided by MarketBeat
Stopped prediction by StockNews_com for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.42
11.03.23
11.03.23
-
11.03.24
11.03.24
-21.70%
12.03.24
12.03.24
